Skip to main content

pharma courses

Work for M.Pharm/ M.Sc as Clinical Research Associate - Client of Winston HR Services

Our client is highly reputed client since a decade and having a multiple branch in Foreign as well as in INDIA.

Post: Clinical Research Associate

[adsense:336x280:8701650588]

Job as Pharma R&D Team Member in Cipla

Cipla’s journey began in 1935 when our founder, Dr. K. A. Hamied, set up an enterprise with the vision to make India self-sufficient in healthcare. Over the past 77 years, we have emerged as one of the world’s most respected pharmaceutical names, not just in India but worldwide.
We have 34 state-of-the-art manufacturing facilities that make Active Pharmaceutical Ingredients (APIs) and formulations, which have been approved by major international Regulatory Agencies. We have over 2000 products in 65 therapeutic categories; with over 40 dosage forms, covering a wide spectrum of diseases ranging from communicable, non-communicable, common and emerging diseases to even rare diseases.

Post: Pharma R&D Team Member

Notice for Admission to Ph.D. Programme in NISER

Applications are invited from Indian citizens for admission to Ph.D. Programme scheduled to commence from 27th July, 2015 in the following schools of basic sciences at NISER, Bhubaneswar:

School of Biological Sciences

[adsense:336x280:8701650588]

A REVIEW ARTICLE: PRONIOSOMES

{ DOWNLOAD AS PDF }

ABOUT AUTHORS:
Shweta Vashist*, Jyoti Kaushik, Batra K. Sunil
Department of Pharmaceutics,
Hindu College of Pharmacy, Sonipat
shwetavashist55@gmail.com

ABSTRACT:
Skin is the main target of topical and transdermal preparations. Major aim of transdermal drug delivery sytem is to cross the stratum corneum. Now-a-days we better know vesicles have importance in cellular communication. Niosomal carrier are systems containing soft vesicles, composed of non –ionic surfactant and an alternative to liposomes. They can entrap both hydrophilic and hydrophobic chemicals but these types of vesicles include the superior physical stability problems such as aggregation, fusion, and leakage of encapsulated drug. Proniosomes are provesicular approach which overcomes the limitations of vesicular system (Niosomes). Provesicular approach has been proposed to enhance the stability of vesicles. Proniosomes is a compact semi-solid liquid crystalline product of non- ionic surfactant  easily formed on dissolving the surfactant in minimal amount of acceptable solvent and the least amount of aqueous phase. Proniosomes can be converted into niosomes in –situ by absorbing water from the skin.

[adsense:336x280:8701650588]

Applications are invited for Pharmacist (7 Opening) in Office of the Additional Director, CGHS

Applications are invited from the eligible Indian Nationals for ‘C’ Posts of Staff Nurse and Pharmacists fallopathiclfor CGHS Imphal and Agartala as per the following particulars.

Post: Pharmacist

Opportunity for Assistant Professor - Pharmacy in MSU

Mohanlal Sukhadia University (erstwhile Udaipur University) at Udaipur is a State University established by an Act in the year 1962 to cater the needs of higher education in Southern Rajasthan. The University is located in Aravalli Hill Area largely dominated by tribal populations. Endowed with rich cultural heritage, natural resources and beautiful landscape, Udaipur is a world renowned tourist attraction.

On-line applications are invited for appointment of teaching faculties on regular basis for the following posts:

Post: Assistant Professor

DIFFERENCE SPECTROSCOPIC METHOD FOR THE ESTIMATION OF CIPROFLOXACIN HYDROCHLORIDE IN BULK AND IN ITS FORMULATION

{ DOWNLOAD AS PDF }

ABOUT AUTHORS:
Kharat Rekha1*, Jadhav Santosh1, Pawar Seemarani2, Tamboli Ashpak2
1Department of Pharmaceutics, Sahyadri College of Pharmacy, Methwade,
Sangola, Solapur, Maharashtra, India
2Department of Pharmaceutical chemistry, Sahyadri College of Pharmacy, Methwade,
Sangola, Solapur, Maharashtra, India
*kharatrs26@gmail.com

ABSTRACT:
A simple, precise and accurate difference spectroscopic method has been developed for the estimation of Ciprofloxacin Hydrochloride in bulk drug form by difference spectrophotometric method. Ciprofloxacin Hydrochloride has exhibited maximum absorbance at about 272nm and 278nm in acidic and basic solution respectively. Beer’s law was obeyed in the concentration range of 2-10 µg/ml in both the cases. The regression of coefficient was found to be r2=0.9982. The LOD and LOQ value were found to be 0.5140ppm and 0.5577ppm respectively. The proposed method was successfully applied for the determination of Ciprofloxacin Hydrochloride in bulk drug. As per ICH guidelines the result of the analysis were validated statistically and were found to be satisfactory.

Walk in interview for Technical Officer, Laboratory technician in CSTM

Eligible candidates are invited to attend a WALK-IN-INTERVIEW on 02/04/2015 at 11 A.M. at Conference Room (4th, floor) School of Tropical Medicine. 108 Chittaranjan Avenue, Kolkata-73. for the following posts of NFUS 4 project (for 18 months only) on contractual basis funded by International Institute of Population Science, Ministry of Health and Family Welfare. Government of India.

Post: Technical Officer, Laboratory technician

Career as Executive / Sr. Executive / Asst. Manager-SAP IT in Aspiring-Solutions hiring for its pharma client

We are hiring for our well reputed pharma client

Post: Executive / Sr. Executive / Asst. Manager-SAP IT (Mumbai & Mahad)

[adsense:336x280:8701650588]

No.of post: 3 Nos.

Application are invited for B.Pharm/ D.Pharm as Technical Assistant in NEIGRIHMS

NEIGRIHMS was established by the Government of India in 1987. It has been designed as a Postgraduate Medical Institute in lineage of AIIMS, New Delhi and PGIMER, Chandigarh. It is the First Postgraduate Medical Institute in the North Eastern Region and the Third in the Country established by Ministry of Health and Family Welfare, Government of India. The Institute was registered as a Society on 12th January 1987 by the Registrar of Societies, Meghalaya, Shillong under the name of - “North Eastern Indira Gandhi Regional Institute of Health & Medical Sciences”

A STUDY ON DRUG UTILIZATION PATTERN AND EFFECTIVENESS OF ORAL HYPOGLYCEMIC AGENTS IN DIABETES MELLITUS

{ DOWNLOAD AS PDF }

ABOUT AUTHORS:
Alti Aparna1*, Seema Pushpa Latha1, Gopalgari Lakshmi Nagarjun1, Galammagari Nagaraju1, C. Gopinath1, P. Murali Madhav2
1Annamacharya College of Pharmacy, Kadapa, Andhra Pradesh.
2Rajiv Gandhi Institute of Medical Science, Kadapa, Andhra Pradesh.
aparna.althi@gmail.com

ABSTRACT
Introduction: Diabetes mellitus is on alarming rise in India. Drug utilization studies help to identify the adherence to standard guidelines and extent of drug use and to evaluate the rational drug usage.
Aims and objectives: To determine the drug utilization pattern and effectiveness of oral hypoglycemic agents among diabetes mellitus patients.
Materials and methods: It is a prospective observational study carried out for a period of six months at RIMS kadapa, and two others diabetic centers. The diabetic patients who visited the medicine outpatient department were included. After obtaining approval from institutional ethical committee, a structured data collection form was used to collect demographic data, complete prescription details and other relevant information required for the study. The drug utilization pattern was determined. The drugs were categorized by Anatomical therapeutic classification (ATC) and DDD/1000 inhabitants/day was calculated by using WHO guidelines. Among all oral hypoglycemic agents the most effective drug/combination in this region was identified.
RESULTS:  716 prescriptions were assessed out of which,401(56.0%) were females and 315(43.9%) were males, most of the patients were in the age group of 40-60 for males 175(55%) and females 205(51.1%). Hypertension was the most common co-morbid seen. The average number of drugs per prescription was 4.26 and anti-diabetics per prescription was 1.79. DDD/1000 inhabitants/day for metformin (A10BA02) was 10.5, glimiperide (A10BB12) was 9.3, glibenclamide (A10BB01) was 7.91, pioglitazone (A10BG03) was 7.25. Out of 716 patients 311(45.25%) patients were on Monotherapy, and 405 (56.5%) were on Combination therapy.A total of 200 newly diagnosed patients of diabetes mellitus were enrolled in the study out of which only 128 members were followed up successfully. The combinations of Metformin +Sulfonyl Ureas + Others showed a good control of fasting blood sugar when compared with only Metformin, only Sulfonyl Ureas or Metformin +Sulfonyl Ureas, Sulfonyl Ureas + Others.
Conclusion: Metformin was the most utilized drug followed by glimiperide. Combination therapy was most frequent when compared to monotherapy in which metformin+glimiperide was commonly prescribed one. so by understanding  the current prescribing patterns attempts can be made to improve rational prescribing. The combination of Metformin+Sulfonyl Ureas+Others is more effective combination.

DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF LAMOTRIGINE AND CLOZAPINE IN SYNTHETIC MIXTURE BY ABSORPTION CORRECTION METHOD

{ DOWNLOAD AS PDF }

ABOUT AUTHORS:
Priyanka P. Atodariya*, Hasumati A. Raj, Vineet C. Jain
*Shree Dhanvantary Pharmacy Collage, Kim,
Surat, Gujarat, India
*atodariya.priyanka@yahoo.com

ABSTRACT:
The simple spectroscopic method has been developed for simultaneous estimation of Lamotrigine and Clozapine in synthetic mixture. Absorbance Correction Method involves the measurement of absorption at two wavelengths 307 nm (lmaxfor Lamotrigine) and 360 nm (lmax for Clozapine). The method was found linear between the range of 1-5 µg/ml for Lamotrigine and 6-30 µg/ml for Clozapine for method. The accuracy and precision was determined and validated statistically. Both the method showed good reproducibility and recovery with %RSD less than 1. The method was found to be rapid, specific, precise and accurate and can be successfully applied for the routine analysis for Lamotrigine and Clozapine in bulk and combined dosage form.

ANTICONVULSANT EFFECT OF LEAF AND BARK OF ERYTHRINA VARIEGATA LINN AND BUTEA MONOSPERMA (LAM) TAUB IN DIFFERENT EXPERIMENTAL CONVULSION MODEL IN RATS

ABOUT AUTHORS:
Prakash T. Sangale*1, Dhananjay B. Deshmukh2, Rajesh Bhambere3
1Department of Quality Assurance Techniques,
2Department of Pharmacology,
VJSM’S Vishal Institute of Pharmaceutical Education and Research,
Ale, Junnar, Pune
*prakashsangale091@gmail.com

{ DOWNLOAD AS PDF }

ABSTRACT
Epilepsy is a chronic disorder characterized by the occurrence of epileptic seizures, with or without characteristic body movements (convulsion)affecting about 50 million people worldwide. Synthetic drugs for the treatment of epilepsy are associated with severe side effects and addiction liabilities upon long term uses. Thus, researchers around the globe are searching for natural resources.Erythrinavariegata and Butea monosperma is a traditional medicinal plant used to treat a seizure.The present studies reveal that the anticonvulsant activity by Erythrina variegate & Butea monosperma of bark & leaf PTZ and MES induced convulsions in wistar rats using Erythrina variegata & Butea monosperma of bark & leaf ethanolic extracts extracted successively. However, the anticonvulsant activity of this plant has not been studied in depth.

In Pentylene tetrazole (PTZ) an maximal electro shock seizure(MES) models test parameters like latncy, onset of tonic convulsions, clonic convulsions and percent protection were observed in the different test groups. Inconclusion, we showed that the ethanolic extract of Erythrina variegata and Butea monosperma has anticonvulsant effect in the both models, suggesting their possible depressant action in the central nervous system. EEBM and EEEV gave significant protection (P<0.001) against PTZ & MES induce convulsion.

Job as Quality Assurance Expert/consultant (M.Pharm) at Indian Institute of Integrative Medicine

CSIR-Indian Institute of Integrative Medicine, Jammu, has created a State of the Art National Facility namely cGMP pilot Plant for Extraction, Formulation and Packaging of Traditional (ISM) Herbal Medicinal formulations to prepare formulations in the form of a tablet/capsule/liquid, of the extracts and botanical derived APIs for preclinical and clinical trials in accordance with the requirements of regulatory agencies to develop new rational drug formulations, desires to recruit Quality Assurance expert/consultant and Plant Operators on purely temporary basis in the Institute as under:-

Post: Quality Assurance Expert/consultant

Walk in interview for M.Pharm as Project Assistant in SCTIMST

Sree Chitra Tirunal Institute for Medical Sciences & Technology (SCTIMST), Thiruvananthapuram is an Institute of National Importance  established by an Act  of the Indian Parliament  and  under the 2 administrative control of the Department of Science and Technology, Government of India.
The Institute signifies the convergence of Medical Sciences and Technology and its mission is to enable the indigenous growth of biomedical technology, besides demonstrating high standards of patient care in medical specialties and evolving postgraduate training programs. It has a hospital for tertiary care of cardiovascular and neurological diseases, and research programmes in the areas of basic and applied medical sciences,  a Biomedical Technology Wing with facilities  and research programmes for developing medical  devices from a conceptual stage to commercialization, and The Achutha Menon Centre for Health Science Studies for training and research in public health.

For a DBT Project entitled “Mechanism of epileptogenesis in young and adult brain-Role of NMDA receptor subtypes in hippocampal neurons and astrocytes” (P-8084)

Post: Project Assistant

Vacancies for B.Pharm/D.Pharm as Logistic Manager, Consultant in National Health Mission

National Health Mission (NHM), Rajasthan State Health Society, invites applications for various positions of Managers/Consultants/Ofificers/Coordinators and Assistants at State HQ on contractual basis under National Rural Health Mission (NRHM) Rajasthan.

The details of various positions, required essential qualifications & experience, maximum age limit etc.are as under:

Post: Logistic Manager, Consultant

SIMULTANEOUS DETERMINATION OF ITOPRIDE HYDROCHLORIDE AND LANSOPRAZOLE IN SYNTHETIC MIXTURE USING SPECTROPHOTOMETRIC TECHNIQUE (FIRST ORDER DERIVATIVE METHOD

{ DOWNLOAD AS PDF }

ABOUT AUTHORS:
*Ashif I. Bhim1, Farhana V. Buchiy1, Hasumati A. Raj1, Vineet C. Jain2
1Department of Qaulity Assurane, Shree Dhanvantary Pharmacy College, Kim, Surat, Gujarat, India.
2Department of Pharmacognocy, Shree Dhanvantary Pharmacy College, Kim, Surat, Gujarat, India.
bhimiqbal23@gmail.com

ABSTRACT
A simple, accurate and precise spectroscopic method was developed for simultaneous estimation of Itopride Hydrochloride and Lansoprazole in synthetic mixture using first order derivative zero-crossing method. Itopride Hydrochlorideshowed zero crossing point at 278.12nmwhile Lansoprazole showed zero crossing point at 244.58nm. The dA/dλ was measured at 244.12 nm for Itopride Hydrochloride and 278.12nmfor Lansoprazole and calibration curves were plotted as dA/dλ versus concentration, respectively. The method was found to be linear (r2>0.999) in the range of 5-25μg/ml for Itopride Hydrochloride at 244.58nm. The linear correlation was obtained (r2>0.996) in the range of 5-25 μg/ml for Lansoprazole at 278.12 nm. The limit of determination was 0.155μg/ml and 0.059μg/ml forItopride Hydrochloride and Lansoprazole, respectively. The limit of quantification was 0.472μg/ml and 0.179μg/ml for Itopride Hydrochloride and Lansoprazolerespectively. The accuracy of these method were evaluated by recovery studies and good recovery result were obtained greater than 99% shows first order derivation zero crossing. The method was successfully applied for simultaneous determination of Itopride Hydrochloride and Lansoprazolein binary mixture.

PAREXEL International Corporation, a global clinical research organization, announced today that the Company has signed a definitive agreement to acquire all of the business assets of privately-owned Quantum Solutions India (QSI), a leading provider of specialized pharmacovigilance services, based in Chandigarh, India.  Pharmacovigilance refers to the collection, detection, assessment, monitoring, and prevention of adverse effects with pharmaceutical products.  The acquisition is expected to close in early April of 2015, subject to the satisfaction of closing conditions.

According to a new market research report "Tumor Ablation Market by Procedure Volume, Technology (RF, Microwave, Cryoablation, Others), Department (Interventional Radiology, Surgery, Oncology), Application (Liver Cancer, Lung Cancer, Kidney Cancer, Bone Metastasis) - Global Forecasts to 2019", published by MarketsandMarkets, the Tumor Ablation Market is expected to reach around $462.0 Million growing at a CAGR of 11.50% by 2019.

Sun Pharmaceutical Industries Ltd.  begins the integration of Ranbaxy’s business following the successful closure of its merger. The integration, planned by Sun Pharma over many months, will focus on supporting strong growth.

Subscribe to